8-KEarnings & ResultsExhibits & Filings

THERMO FISHER SCIENTIFIC INC. 8-K Report, Financial Results (Oct 25, 2023)

Filed October 25, 2023For Securities:TMO

Summary

Thermo Fisher Scientific Inc. (TMO) filed an 8-K on October 25, 2023, to announce its financial results for the fiscal quarter ended September 30, 2023. The press release containing these results, furnished as Exhibit 99.1, is the primary focus of this filing, providing investors with key performance indicators and financial condition details for the period. Investors should review the furnished press release for specific figures related to revenue, earnings, and any forward-looking statements or guidance provided by the company. This filing serves as the official communication channel for TMO's third-quarter performance. While the 8-K itself is brief, it directs stakeholders to the comprehensive press release for the substantive financial information. This includes insights into the company's operational performance, segment results, and overall financial health, which are crucial for assessing the company's trajectory and investment potential.

Key Highlights

  • 1Announcement of Q3 2023 financial results on October 25, 2023.
  • 2The press release containing detailed financial results is furnished as Exhibit 99.1.
  • 3The filing is made under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits).
  • 4Information provided is not deemed 'filed' for certain sections of the Securities Exchange Act of 1934, but incorporated by reference in other filings as specified.
  • 5Investors are directed to the press release for specific financial data and commentary.
  • 6This 8-K serves as the official notification of the company's quarterly performance.

Frequently Asked Questions

The detailed financial results are provided in the press release dated October 25, 2023, which is furnished as Exhibit 99.1 to this Form 8-K. You should refer to this exhibit for specific revenue, earnings, and other financial performance data.

This 8-K filing officially announces Thermo Fisher Scientific's financial results for the fiscal quarter ended September 30, 2023. It serves as the primary vehicle to furnish the accompanying press release containing these important financial updates to investors and the public.

While the 8-K itself does not contain the financial details, the furnished press release (Exhibit 99.1) typically includes management's commentary, analysis of results, and any forward-looking guidance or outlook the company is providing for future periods. Investors should consult the press release for this information.

No, the information contained in this report and its exhibits is furnished and shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section. However, it may be incorporated by reference in other SEC filings if specifically stated.